Computational Biology Market Size & Share, by Application (Cellular & Biological Simulation, Drug Discovery, Disease Modelling, Preclinical Drug Development, Clinical Trials, Human Body Simulation); Component (Databases, Infrastructure Hardware, Analysis Services); End-user (Academics, Industrial, Commercials) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

Request Free Sample Copy

Report ID: 3921
Published Date: May 30, 2023
Report Format: PDF, PPT

Buy Now

Companies dominating the Global Computational Biology Landscape

Dassault Systèmes SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Certara Inc.
Instem Group
Compugen
Chemical Computing Group ULC
Rhenovia Pharma SAS
Nimbus Discovery LLC
Rhenovia Pharma SAS
Insilico Biotechnology AG
Genedata AG

Browse Key Market Insights with Data Illustration:

Computational Biology Market Size & Share | Growth Trends 2023-2035

In the News

Certara Inc. announced that the U.S. Food and Drug Administration (FDA) has renewed and expanded the company’s licenses of Certra’s proprietarybiosimulation software along with other 400 user licenses of Phoenix software and Simcyp.

Instem Group declared the acquisition of Edge Software Consultancy Ltd to expand its portfolio to discover R&D activities thereby bringing the client products into the market at a faster rate. The technology and services of the Edge helped to enhance the research and development activities of drug discovery and increased client productivity.

Frequently Asked Questions (FAQ)

Increasing investment in research and development activities and growing demand for bioinformatics are the major factors driving the market growth.

The market size of computational biology is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2023-2035.

Lack of enough researchers and dearth of trained professionals are estimated to be the growth hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Certara Inc., Instem Group, Compugen, Chemical Computing Group ULC, Rhenovia Pharma SAS, Nimbus Discovery LLC, Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by application, component, end-user, and by region.

The commercial segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Companies dominating the Global Computational Biology Landscape

Browse Key Market Insights with Data Illustration:

In the News

Frequently Asked Questions (FAQ)

What are the major factors driving the growth of the computational biology market?

What would be the CAGR of computational biology market over the forecast period?

What are the challenges affecting the computational biology market growth?

Which region will provide more business opportunities for growth of computational biology market in future?

Who are the major players dominating the computational biology market?

How are the company profiles selected?

What are the segments in the computational biology market?

Which segment captures the largest market size in end-user segment in the computational biology market?